Concepedia

Author

L. P. Bloss

Eli Lilly (United States)

Also Known As

L. Bloss, L. P. Bloss, L.P. Bloss, Leslie P. Bloss

26

Publications

486

Citations

8

H-Index

16

Concepts

All Affiliations

Eli Lilly (United States)University of California, Irvine Medical Center
LP

About

L. P. Bloss is an author at Eli Lilly (United States) specializing in medicine, surgery, and gynecologic surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

410

2

Obstetrics

3

3

377

3

Surgical Oncology

2

2

289

4

Health Sciences

1

1

22

5

Pathology

1

1

11

L. P. Bloss

×

6

Publications

424

Citations

6

H-Index

YearCitations

Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the Ovary

Jeffrey D. Bloss, Shu‐Yuan Liao, Richard E. Buller,

Gynecologic Oncology

1993

266

Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient

Jeffrey D. Bloss, Michael L. Berman, L. P. Bloss,

Gynecologic Oncology

1991

88

Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary

J. Bloss, S Y Liao, R.E. Buller,

International Journal of Gynecology & Obstetrics

1994

23

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

Gregory A. Masters, Athanassios Argiris, Elizabeth A. Hahn,

Journal of Thoracic Oncology

2006

22

A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors

Arkadiusz Z. Dudek, T. A. Larson, C. E. Mellskog,

Journal of Clinical Oncology

2004

14

Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules

Coleman K. Obasaju, Zhishen Ye, L. P. Bloss,

Clinical Lung Cancer

2005

11

Page 1